Life Summary
Kim Gun-soo is the CEO of Curocell.

He aims to transform the company into a digital platform enterprise specializing in CAR-T and cell and gene therapies.

Born in July 1975, Kim earned his undergraduate degree in biotechnology from Yonsei University and received a master’s degree in immunology from the university’s graduate school.

He built his expertise and professional experience in research and strategic planning through roles at Hanwha Chemical Central Research Institute, LG Life Sciences, and CHA Biotech.

In December 2016, Kim co-founded Curocell with Kim Chan-hyuk, a life sciences expert and professor at KAIST (Korea Advanced Institute of Science and Technology), and Shim Hyun-bo, an antibody specialist and professor at Ewha Womans University School of Medicine.

Curocell is now on the verge of launching a breakthrough cancer therapy based on CAR-T cells.

Kim is recognized for combining medical technology expertise, strong business execution, and digital innovation capabilities.

#Curocell #KimGunsoo #CARTtherapy #CellTherapy #GeneTherapy #BiotechStartup #DigitalHealth #KoreanBiotech #MedicalInnovation #Immunotherapy